After parting ways with BeiGene in 2023, Novartis effectively bowed out of the PD-1 race. | The rising class of bisepcifics ...

Cargo Therapeutics, a Bay Area biotech firm, is laying off half its staff after having to shut down a promising drug ...

HC Wainwright decreased their FY2024 earnings per share estimates for uniQure in a report released on Monday, January 27th. HC Wainwright analyst P. Trucchio now anticipates that the biotechnology ...

A groundbreaking leader in Biotech was a guest speaker Thursday night at the Hatfield Hall Theater at Rose Hulman. Nina ...

BHUBANESWAR: Odisha has received investment intents to the tune of Rs 4,349 crore in the healthcare sector during the two-day ...

U.S. Rep. April McClain Delaney visited Kite, a biopharmaceutical company that uses cell therapy to treat cancer, in Urbana ...

Fate Therapeutics, Inc. (NASDAQ:FATE), a clinical-stage biopharmaceutical company with a market capitalization of $156.6 million, is at a pivotal juncture in its development of programmed cellular ...

Maze Therapeutics said on Thursday that it raised $140 million in an initial public offering, setting the stage for a debut that could make the kidney disease drug developer the first U.S. biotech ...

We recently compiled a list of the 12 Stocks That Will Double in 2025. In this article, we are going to take a look at where ...

The glut of life science office and lab space in San Diego County rose to an all-time high in 2024 and it’s expected to ...